Key result
Robotic mitral valve surgery using the da Vinci system enables complex operations through small port sites with procedural success, though high costs necessitate justification.
Robotic mitral valve surgery is feasible and less traumatic, but requires economic justification compared to conventional approaches.
Robotic mitral valve surgery remains investigational; leaves open cost-effectiveness versus conventional approaches in broader populations.
A renaissance in cardiac surgery is occurring. Cardiac operations are being performed through smaller incisions with enhanced technologic assistance. Specifically, minimally invasive mitral valve surgery has become standard for many surgeons. At our institution, we have developed a robotic mitral surgery program with the da Vinci telemanipulation system, which has recently gained Food and Drug Administration approval. This system allows the surgeon to perform complex mitral valve operations through small port sites rather than a traditional median sternotomy. Our techniques and initial results are reported. Despite procedural success, these devices are not inexpensive and hospitals will have to justify their purchase. The implementation of robotic surgery has forced us to compare costs and benefits compared with conventional cardiac surgery. Nevertheless, our desire for improved and less traumatic patient care will drive this new technology, which will serve as a good model for us to study over the next several years.
No takes yet. Share an insight, caveat, or question.
Chitwood et al. (2003) studied Mitral valve disease. Robotic mitral valve surgery (da Vinci telemanipulation system) vs. Conventional cardiac surgery (median sternotomy) was evaluated. Robotic mitral valve surgery using the da Vinci system enables complex operations through small port sites with procedural success, though high costs necessitate justification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: